Revised EU Pharmaceutical Legislation and its impact for Swiss Life Sciences

Rapid developments in the pharmaceutical industry require the adaptation of EU legislations. We are taking a look at what the upcoming regulatory change means for Swiss Life Sciences Companies and what effects are to be expected.

Fill in the form below to receive the PDF via email.